OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023 - OPKO Health (NASDAQ:OPK)

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) will present late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney

Related Keywords

United States ,Philadelphia ,Pennsylvania ,Miami ,Florida ,American ,Charlesw Bishop ,Akhtar Ashfaq ,Lyvonne Briggs ,Bruce Voss ,Stephena Strugnell ,Health Inc ,Drug Administration ,American Society Of Nephrology ,Exchange Commission ,American Society ,Kidney Week ,Secondary Hyperparathyroidism ,Extended Release Calcifediol ,Exhibit Hallsb D ,Calcifediol Overcomes Impact ,Mineral Metabolism ,Exhibit Halls ,Release Calcifediol ,Data Journey ,Real World Evidence Highlights ,Early Treatment ,Private Securities Litigation Reform Act ,Annual Reports ,